Pharma & Healthcare
Global GLP-1 Therapy Market Research Report 2025
- Dec 02, 25
- ID: 612564
- Pages: 78
- Figures: 79
- Views: 9
Report Scope
This report aims to provide a comprehensive presentation of the global market for GLP-1 Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Therapy.
The GLP-1 Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP-1 Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Feature and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Feature and by regions.
By Company
Novo Nordisk
Eli Lilly
Sanofi
AstraZeneca (historical)
Teva
Zealand Pharma
Pfizer
Merck (MSD)
Segment by Type
Injection
Oral
Segment by Feature
Long-acting Drugs
Short-acting Drugs
Segment by Channel
Online Sales
Offline Sales
Segment by Application
Type 2 Diabetes
Obesity/Weight Management
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1 Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP-1 Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for GLP-1 Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Therapy.
The GLP-1 Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP-1 Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Feature and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Feature and by regions.
By Company
Novo Nordisk
Eli Lilly
Sanofi
AstraZeneca (historical)
Teva
Zealand Pharma
Pfizer
Merck (MSD)
Segment by Type
Injection
Oral
Segment by Feature
Long-acting Drugs
Short-acting Drugs
Segment by Channel
Online Sales
Offline Sales
Segment by Application
Type 2 Diabetes
Obesity/Weight Management
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1 Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP-1 Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 GLP-1 Therapy Market Overview
1.1 Product Definition
1.2 GLP-1 Therapy by Type
1.2.1 Global GLP-1 Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Oral
1.3 GLP-1 Therapy by Feature
1.3.1 Global GLP-1 Therapy Market Value Comparison by Feature: 2024 VS 2031
1.3.2 Long-acting Drugs
1.3.3 Short-acting Drugs
1.4 GLP-1 Therapy by Channel
1.4.1 Global GLP-1 Therapy Market Value Comparison by Channel: 2024 VS 2031
1.4.2 Online Sales
1.4.3 Offline Sales
1.5 GLP-1 Therapy by Application
1.5.1 Global GLP-1 Therapy Market Value by Application (2024 VS 2031)
1.5.2 Type 2 Diabetes
1.5.3 Obesity/Weight Management
1.5.4 Other
1.6 Global GLP-1 Therapy Market Size Estimates and Forecasts
1.6.1 Global GLP-1 Therapy Revenue 2020-2031
1.6.2 Global GLP-1 Therapy Sales 2020-2031
1.6.3 Global GLP-1 Therapy Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 GLP-1 Therapy Market Competition by Manufacturers
2.1 Global GLP-1 Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global GLP-1 Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GLP-1 Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GLP-1 Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Therapy, Product Type & Application
2.7 Global Key Manufacturers of GLP-1 Therapy, Date of Enter into This Industry
2.8 Global GLP-1 Therapy Market Competitive Situation and Trends
2.8.1 Global GLP-1 Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1 Therapy Players Market Share by Revenue
2.8.3 Global GLP-1 Therapy Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Therapy Market Scenario by Region
3.1 Global GLP-1 Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GLP-1 Therapy Sales by Region: 2020-2031
3.2.1 Global GLP-1 Therapy Sales by Region: 2020-2025
3.2.2 Global GLP-1 Therapy Sales by Region: 2026-2031
3.3 Global GLP-1 Therapy Revenue by Region: 2020-2031
3.3.1 Global GLP-1 Therapy Revenue by Region: 2020-2025
3.3.2 Global GLP-1 Therapy Revenue by Region: 2026-2031
3.4 North America GLP-1 Therapy Market Facts & Figures by Country
3.4.1 North America GLP-1 Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GLP-1 Therapy Sales by Country (2020-2031)
3.4.3 North America GLP-1 Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Therapy Market Facts & Figures by Country
3.5.1 Europe GLP-1 Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GLP-1 Therapy Sales by Country (2020-2031)
3.5.3 Europe GLP-1 Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GLP-1 Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific GLP-1 Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Therapy Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GLP-1 Therapy Sales by Country (2020-2031)
3.7.3 Latin America GLP-1 Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GLP-1 Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa GLP-1 Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Therapy Sales by Type (2020-2031)
4.1.1 Global GLP-1 Therapy Sales by Type (2020-2025)
4.1.2 Global GLP-1 Therapy Sales by Type (2026-2031)
4.1.3 Global GLP-1 Therapy Sales Market Share by Type (2020-2031)
4.2 Global GLP-1 Therapy Revenue by Type (2020-2031)
4.2.1 Global GLP-1 Therapy Revenue by Type (2020-2025)
4.2.2 Global GLP-1 Therapy Revenue by Type (2026-2031)
4.2.3 Global GLP-1 Therapy Revenue Market Share by Type (2020-2031)
4.3 Global GLP-1 Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global GLP-1 Therapy Sales by Application (2020-2031)
5.1.1 Global GLP-1 Therapy Sales by Application (2020-2025)
5.1.2 Global GLP-1 Therapy Sales by Application (2026-2031)
5.1.3 Global GLP-1 Therapy Sales Market Share by Application (2020-2031)
5.2 Global GLP-1 Therapy Revenue by Application (2020-2031)
5.2.1 Global GLP-1 Therapy Revenue by Application (2020-2025)
5.2.2 Global GLP-1 Therapy Revenue by Application (2026-2031)
5.2.3 Global GLP-1 Therapy Revenue Market Share by Application (2020-2031)
5.3 Global GLP-1 Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk GLP-1 Therapy Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly GLP-1 Therapy Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi GLP-1 Therapy Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 AstraZeneca (historical)
6.4.1 AstraZeneca (historical) Company Information
6.4.2 AstraZeneca (historical) Description and Business Overview
6.4.3 AstraZeneca (historical) GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca (historical) GLP-1 Therapy Product Portfolio
6.4.5 AstraZeneca (historical) Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva GLP-1 Therapy Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Zealand Pharma
6.6.1 Zealand Pharma Company Information
6.6.2 Zealand Pharma Description and Business Overview
6.6.3 Zealand Pharma GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zealand Pharma GLP-1 Therapy Product Portfolio
6.6.5 Zealand Pharma Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer GLP-1 Therapy Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Merck (MSD)
6.8.1 Merck (MSD) Company Information
6.8.2 Merck (MSD) Description and Business Overview
6.8.3 Merck (MSD) GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck (MSD) GLP-1 Therapy Product Portfolio
6.8.5 Merck (MSD) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Therapy Industry Chain Analysis
7.2 GLP-1 Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Therapy Production Mode & Process Analysis
7.4 GLP-1 Therapy Sales and Marketing
7.4.1 GLP-1 Therapy Sales Channels
7.4.2 GLP-1 Therapy Distributors
7.5 GLP-1 Therapy Customer Analysis
8 GLP-1 Therapy Market Dynamics
8.1 GLP-1 Therapy Industry Trends
8.2 GLP-1 Therapy Market Drivers
8.3 GLP-1 Therapy Market Challenges
8.4 GLP-1 Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 GLP-1 Therapy by Type
1.2.1 Global GLP-1 Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Oral
1.3 GLP-1 Therapy by Feature
1.3.1 Global GLP-1 Therapy Market Value Comparison by Feature: 2024 VS 2031
1.3.2 Long-acting Drugs
1.3.3 Short-acting Drugs
1.4 GLP-1 Therapy by Channel
1.4.1 Global GLP-1 Therapy Market Value Comparison by Channel: 2024 VS 2031
1.4.2 Online Sales
1.4.3 Offline Sales
1.5 GLP-1 Therapy by Application
1.5.1 Global GLP-1 Therapy Market Value by Application (2024 VS 2031)
1.5.2 Type 2 Diabetes
1.5.3 Obesity/Weight Management
1.5.4 Other
1.6 Global GLP-1 Therapy Market Size Estimates and Forecasts
1.6.1 Global GLP-1 Therapy Revenue 2020-2031
1.6.2 Global GLP-1 Therapy Sales 2020-2031
1.6.3 Global GLP-1 Therapy Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 GLP-1 Therapy Market Competition by Manufacturers
2.1 Global GLP-1 Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global GLP-1 Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GLP-1 Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GLP-1 Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Therapy, Product Type & Application
2.7 Global Key Manufacturers of GLP-1 Therapy, Date of Enter into This Industry
2.8 Global GLP-1 Therapy Market Competitive Situation and Trends
2.8.1 Global GLP-1 Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1 Therapy Players Market Share by Revenue
2.8.3 Global GLP-1 Therapy Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Therapy Market Scenario by Region
3.1 Global GLP-1 Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GLP-1 Therapy Sales by Region: 2020-2031
3.2.1 Global GLP-1 Therapy Sales by Region: 2020-2025
3.2.2 Global GLP-1 Therapy Sales by Region: 2026-2031
3.3 Global GLP-1 Therapy Revenue by Region: 2020-2031
3.3.1 Global GLP-1 Therapy Revenue by Region: 2020-2025
3.3.2 Global GLP-1 Therapy Revenue by Region: 2026-2031
3.4 North America GLP-1 Therapy Market Facts & Figures by Country
3.4.1 North America GLP-1 Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GLP-1 Therapy Sales by Country (2020-2031)
3.4.3 North America GLP-1 Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Therapy Market Facts & Figures by Country
3.5.1 Europe GLP-1 Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GLP-1 Therapy Sales by Country (2020-2031)
3.5.3 Europe GLP-1 Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GLP-1 Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific GLP-1 Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Therapy Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GLP-1 Therapy Sales by Country (2020-2031)
3.7.3 Latin America GLP-1 Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GLP-1 Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa GLP-1 Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Therapy Sales by Type (2020-2031)
4.1.1 Global GLP-1 Therapy Sales by Type (2020-2025)
4.1.2 Global GLP-1 Therapy Sales by Type (2026-2031)
4.1.3 Global GLP-1 Therapy Sales Market Share by Type (2020-2031)
4.2 Global GLP-1 Therapy Revenue by Type (2020-2031)
4.2.1 Global GLP-1 Therapy Revenue by Type (2020-2025)
4.2.2 Global GLP-1 Therapy Revenue by Type (2026-2031)
4.2.3 Global GLP-1 Therapy Revenue Market Share by Type (2020-2031)
4.3 Global GLP-1 Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global GLP-1 Therapy Sales by Application (2020-2031)
5.1.1 Global GLP-1 Therapy Sales by Application (2020-2025)
5.1.2 Global GLP-1 Therapy Sales by Application (2026-2031)
5.1.3 Global GLP-1 Therapy Sales Market Share by Application (2020-2031)
5.2 Global GLP-1 Therapy Revenue by Application (2020-2031)
5.2.1 Global GLP-1 Therapy Revenue by Application (2020-2025)
5.2.2 Global GLP-1 Therapy Revenue by Application (2026-2031)
5.2.3 Global GLP-1 Therapy Revenue Market Share by Application (2020-2031)
5.3 Global GLP-1 Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk GLP-1 Therapy Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly GLP-1 Therapy Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi GLP-1 Therapy Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 AstraZeneca (historical)
6.4.1 AstraZeneca (historical) Company Information
6.4.2 AstraZeneca (historical) Description and Business Overview
6.4.3 AstraZeneca (historical) GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca (historical) GLP-1 Therapy Product Portfolio
6.4.5 AstraZeneca (historical) Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva GLP-1 Therapy Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Zealand Pharma
6.6.1 Zealand Pharma Company Information
6.6.2 Zealand Pharma Description and Business Overview
6.6.3 Zealand Pharma GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zealand Pharma GLP-1 Therapy Product Portfolio
6.6.5 Zealand Pharma Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer GLP-1 Therapy Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Merck (MSD)
6.8.1 Merck (MSD) Company Information
6.8.2 Merck (MSD) Description and Business Overview
6.8.3 Merck (MSD) GLP-1 Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck (MSD) GLP-1 Therapy Product Portfolio
6.8.5 Merck (MSD) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Therapy Industry Chain Analysis
7.2 GLP-1 Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Therapy Production Mode & Process Analysis
7.4 GLP-1 Therapy Sales and Marketing
7.4.1 GLP-1 Therapy Sales Channels
7.4.2 GLP-1 Therapy Distributors
7.5 GLP-1 Therapy Customer Analysis
8 GLP-1 Therapy Market Dynamics
8.1 GLP-1 Therapy Industry Trends
8.2 GLP-1 Therapy Market Drivers
8.3 GLP-1 Therapy Market Challenges
8.4 GLP-1 Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global GLP-1 Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global GLP-1 Therapy Market Value by Feature, (US$ Million) & (2024 VS 2031)
Table 3. Global GLP-1 Therapy Market Value by Channel, (US$ Million) & (2024 VS 2031)
Table 4. Global GLP-1 Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global GLP-1 Therapy Market Competitive Situation by Manufacturers in 2024
Table 6. Global GLP-1 Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 7. Global GLP-1 Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global GLP-1 Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global GLP-1 Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market GLP-1 Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of GLP-1 Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of GLP-1 Therapy, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of GLP-1 Therapy, Product Type & Application
Table 14. Global Key Manufacturers of GLP-1 Therapy, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global GLP-1 Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Therapy as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global GLP-1 Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global GLP-1 Therapy Sales by Region (2020-2025) & (K Units)
Table 20. Global GLP-1 Therapy Sales Market Share by Region (2020-2025)
Table 21. Global GLP-1 Therapy Sales by Region (2026-2031) & (K Units)
Table 22. Global GLP-1 Therapy Sales Market Share by Region (2026-2031)
Table 23. Global GLP-1 Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global GLP-1 Therapy Revenue Market Share by Region (2020-2025)
Table 25. Global GLP-1 Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global GLP-1 Therapy Revenue Market Share by Region (2026-2031)
Table 27. North America GLP-1 Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America GLP-1 Therapy Sales by Country (2020-2025) & (K Units)
Table 29. North America GLP-1 Therapy Sales by Country (2026-2031) & (K Units)
Table 30. North America GLP-1 Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America GLP-1 Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe GLP-1 Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe GLP-1 Therapy Sales by Country (2020-2025) & (K Units)
Table 34. Europe GLP-1 Therapy Sales by Country (2026-2031) & (K Units)
Table 35. Europe GLP-1 Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe GLP-1 Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific GLP-1 Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific GLP-1 Therapy Sales by Region (2020-2025) & (K Units)
Table 39. Asia Pacific GLP-1 Therapy Sales by Region (2026-2031) & (K Units)
Table 40. Asia Pacific GLP-1 Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific GLP-1 Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America GLP-1 Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America GLP-1 Therapy Sales by Country (2020-2025) & (K Units)
Table 44. Latin America GLP-1 Therapy Sales by Country (2026-2031) & (K Units)
Table 45. Latin America GLP-1 Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America GLP-1 Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa GLP-1 Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa GLP-1 Therapy Sales by Country (2020-2025) & (K Units)
Table 49. Middle East and Africa GLP-1 Therapy Sales by Country (2026-2031) & (K Units)
Table 50. Middle East and Africa GLP-1 Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa GLP-1 Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global GLP-1 Therapy Sales (K Units) by Type (2020-2025)
Table 53. Global GLP-1 Therapy Sales (K Units) by Type (2026-2031)
Table 54. Global GLP-1 Therapy Sales Market Share by Type (2020-2025)
Table 55. Global GLP-1 Therapy Sales Market Share by Type (2026-2031)
Table 56. Global GLP-1 Therapy Revenue (US$ Million) by Type (2020-2025)
Table 57. Global GLP-1 Therapy Revenue (US$ Million) by Type (2026-2031)
Table 58. Global GLP-1 Therapy Revenue Market Share by Type (2020-2025)
Table 59. Global GLP-1 Therapy Revenue Market Share by Type (2026-2031)
Table 60. Global GLP-1 Therapy Price (US$/Unit) by Type (2020-2025)
Table 61. Global GLP-1 Therapy Price (US$/Unit) by Type (2026-2031)
Table 62. Global GLP-1 Therapy Sales (K Units) by Application (2020-2025)
Table 63. Global GLP-1 Therapy Sales (K Units) by Application (2026-2031)
Table 64. Global GLP-1 Therapy Sales Market Share by Application (2020-2025)
Table 65. Global GLP-1 Therapy Sales Market Share by Application (2026-2031)
Table 66. Global GLP-1 Therapy Revenue (US$ Million) by Application (2020-2025)
Table 67. Global GLP-1 Therapy Revenue (US$ Million) by Application (2026-2031)
Table 68. Global GLP-1 Therapy Revenue Market Share by Application (2020-2025)
Table 69. Global GLP-1 Therapy Revenue Market Share by Application (2026-2031)
Table 70. Global GLP-1 Therapy Price (US$/Unit) by Application (2020-2025)
Table 71. Global GLP-1 Therapy Price (US$/Unit) by Application (2026-2031)
Table 72. Novo Nordisk Company Information
Table 73. Novo Nordisk Description and Business Overview
Table 74. Novo Nordisk GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Novo Nordisk GLP-1 Therapy Product
Table 76. Novo Nordisk Recent Developments/Updates
Table 77. Eli Lilly Company Information
Table 78. Eli Lilly Description and Business Overview
Table 79. Eli Lilly GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Eli Lilly GLP-1 Therapy Product
Table 81. Eli Lilly Recent Developments/Updates
Table 82. Sanofi Company Information
Table 83. Sanofi Description and Business Overview
Table 84. Sanofi GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi GLP-1 Therapy Product
Table 86. Sanofi Recent Developments/Updates
Table 87. AstraZeneca (historical) Company Information
Table 88. AstraZeneca (historical) Description and Business Overview
Table 89. AstraZeneca (historical) GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. AstraZeneca (historical) GLP-1 Therapy Product
Table 91. AstraZeneca (historical) Recent Developments/Updates
Table 92. Teva Company Information
Table 93. Teva Description and Business Overview
Table 94. Teva GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Teva GLP-1 Therapy Product
Table 96. Teva Recent Developments/Updates
Table 97. Zealand Pharma Company Information
Table 98. Zealand Pharma Description and Business Overview
Table 99. Zealand Pharma GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Zealand Pharma GLP-1 Therapy Product
Table 101. Zealand Pharma Recent Developments/Updates
Table 102. Pfizer Company Information
Table 103. Pfizer Description and Business Overview
Table 104. Pfizer GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Pfizer GLP-1 Therapy Product
Table 106. Pfizer Recent Developments/Updates
Table 107. Merck (MSD) Company Information
Table 108. Merck (MSD) Description and Business Overview
Table 109. Merck (MSD) GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Merck (MSD) GLP-1 Therapy Product
Table 111. Merck (MSD) Recent Developments/Updates
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. GLP-1 Therapy Distributors List
Table 115. GLP-1 Therapy Customers List
Table 116. GLP-1 Therapy Market Trends
Table 117. GLP-1 Therapy Market Drivers
Table 118. GLP-1 Therapy Market Challenges
Table 119. GLP-1 Therapy Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Authors List of This Report
List of Figures
Figure 1. Product Picture of GLP-1 Therapy
Figure 2. Global GLP-1 Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GLP-1 Therapy Market Share by Type: 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Oral Product Picture
Figure 6. Global GLP-1 Therapy Market Value by Feature, (US$ Million) & (2020-2031)
Figure 7. Global GLP-1 Therapy Market Share by Feature: 2024 VS 2031
Figure 8. Long-acting Drugs Product Picture
Figure 9. Short-acting Drugs Product Picture
Figure 10. Global GLP-1 Therapy Market Value by Channel, (US$ Million) & (2020-2031)
Figure 11. Global GLP-1 Therapy Market Share by Channel: 2024 VS 2031
Figure 12. Online Sales Product Picture
Figure 13. Offline Sales Product Picture
Figure 14. Global GLP-1 Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 15. Global GLP-1 Therapy Market Share by Application: 2024 & 2031
Figure 16. Type 2 Diabetes
Figure 17. Obesity/Weight Management
Figure 18. Other
Figure 19. Global GLP-1 Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global GLP-1 Therapy Market Size (2020-2031) & (US$ Million)
Figure 21. Global GLP-1 Therapy Sales (2020-2031) & (K Units)
Figure 22. Global GLP-1 Therapy Average Price (US$/Unit) & (2020-2031)
Figure 23. GLP-1 Therapy Report Years Considered
Figure 24. GLP-1 Therapy Sales Share by Manufacturers in 2024
Figure 25. Global GLP-1 Therapy Revenue Share by Manufacturers in 2024
Figure 26. Global 5 and 10 Largest GLP-1 Therapy Players: Market Share by Revenue in GLP-1 Therapy in 2024
Figure 27. GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Global GLP-1 Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 29. North America GLP-1 Therapy Sales Market Share by Country (2020-2031)
Figure 30. North America GLP-1 Therapy Revenue Market Share by Country (2020-2031)
Figure 31. United States GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Canada GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Europe GLP-1 Therapy Sales Market Share by Country (2020-2031)
Figure 34. Europe GLP-1 Therapy Revenue Market Share by Country (2020-2031)
Figure 35. Germany GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. France GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. U.K. GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Italy GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Russia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific GLP-1 Therapy Sales Market Share by Region (2020-2031)
Figure 41. Asia Pacific GLP-1 Therapy Revenue Market Share by Region (2020-2031)
Figure 42. China GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Japan GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. South Korea GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. India GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Australia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. China Taiwan GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Southeast Asia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America GLP-1 Therapy Sales Market Share by Country (2020-2031)
Figure 50. Latin America GLP-1 Therapy Revenue Market Share by Country (2020-2031)
Figure 51. Mexico GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Colombia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa GLP-1 Therapy Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa GLP-1 Therapy Revenue Market Share by Country (2020-2031)
Figure 57. Turkey GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of GLP-1 Therapy by Type (2020-2031)
Figure 61. Global Revenue Market Share of GLP-1 Therapy by Type (2020-2031)
Figure 62. Global GLP-1 Therapy Price (US$/Unit) by Type (2020-2031)
Figure 63. Global Sales Market Share of GLP-1 Therapy by Application (2020-2031)
Figure 64. Global Revenue Market Share of GLP-1 Therapy by Application (2020-2031)
Figure 65. Global GLP-1 Therapy Price (US$/Unit) by Application (2020-2031)
Figure 66. GLP-1 Therapy Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global GLP-1 Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global GLP-1 Therapy Market Value by Feature, (US$ Million) & (2024 VS 2031)
Table 3. Global GLP-1 Therapy Market Value by Channel, (US$ Million) & (2024 VS 2031)
Table 4. Global GLP-1 Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global GLP-1 Therapy Market Competitive Situation by Manufacturers in 2024
Table 6. Global GLP-1 Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 7. Global GLP-1 Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global GLP-1 Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global GLP-1 Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market GLP-1 Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of GLP-1 Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of GLP-1 Therapy, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of GLP-1 Therapy, Product Type & Application
Table 14. Global Key Manufacturers of GLP-1 Therapy, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global GLP-1 Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Therapy as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global GLP-1 Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global GLP-1 Therapy Sales by Region (2020-2025) & (K Units)
Table 20. Global GLP-1 Therapy Sales Market Share by Region (2020-2025)
Table 21. Global GLP-1 Therapy Sales by Region (2026-2031) & (K Units)
Table 22. Global GLP-1 Therapy Sales Market Share by Region (2026-2031)
Table 23. Global GLP-1 Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global GLP-1 Therapy Revenue Market Share by Region (2020-2025)
Table 25. Global GLP-1 Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global GLP-1 Therapy Revenue Market Share by Region (2026-2031)
Table 27. North America GLP-1 Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America GLP-1 Therapy Sales by Country (2020-2025) & (K Units)
Table 29. North America GLP-1 Therapy Sales by Country (2026-2031) & (K Units)
Table 30. North America GLP-1 Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America GLP-1 Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe GLP-1 Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe GLP-1 Therapy Sales by Country (2020-2025) & (K Units)
Table 34. Europe GLP-1 Therapy Sales by Country (2026-2031) & (K Units)
Table 35. Europe GLP-1 Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe GLP-1 Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific GLP-1 Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific GLP-1 Therapy Sales by Region (2020-2025) & (K Units)
Table 39. Asia Pacific GLP-1 Therapy Sales by Region (2026-2031) & (K Units)
Table 40. Asia Pacific GLP-1 Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific GLP-1 Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America GLP-1 Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America GLP-1 Therapy Sales by Country (2020-2025) & (K Units)
Table 44. Latin America GLP-1 Therapy Sales by Country (2026-2031) & (K Units)
Table 45. Latin America GLP-1 Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America GLP-1 Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa GLP-1 Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa GLP-1 Therapy Sales by Country (2020-2025) & (K Units)
Table 49. Middle East and Africa GLP-1 Therapy Sales by Country (2026-2031) & (K Units)
Table 50. Middle East and Africa GLP-1 Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa GLP-1 Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global GLP-1 Therapy Sales (K Units) by Type (2020-2025)
Table 53. Global GLP-1 Therapy Sales (K Units) by Type (2026-2031)
Table 54. Global GLP-1 Therapy Sales Market Share by Type (2020-2025)
Table 55. Global GLP-1 Therapy Sales Market Share by Type (2026-2031)
Table 56. Global GLP-1 Therapy Revenue (US$ Million) by Type (2020-2025)
Table 57. Global GLP-1 Therapy Revenue (US$ Million) by Type (2026-2031)
Table 58. Global GLP-1 Therapy Revenue Market Share by Type (2020-2025)
Table 59. Global GLP-1 Therapy Revenue Market Share by Type (2026-2031)
Table 60. Global GLP-1 Therapy Price (US$/Unit) by Type (2020-2025)
Table 61. Global GLP-1 Therapy Price (US$/Unit) by Type (2026-2031)
Table 62. Global GLP-1 Therapy Sales (K Units) by Application (2020-2025)
Table 63. Global GLP-1 Therapy Sales (K Units) by Application (2026-2031)
Table 64. Global GLP-1 Therapy Sales Market Share by Application (2020-2025)
Table 65. Global GLP-1 Therapy Sales Market Share by Application (2026-2031)
Table 66. Global GLP-1 Therapy Revenue (US$ Million) by Application (2020-2025)
Table 67. Global GLP-1 Therapy Revenue (US$ Million) by Application (2026-2031)
Table 68. Global GLP-1 Therapy Revenue Market Share by Application (2020-2025)
Table 69. Global GLP-1 Therapy Revenue Market Share by Application (2026-2031)
Table 70. Global GLP-1 Therapy Price (US$/Unit) by Application (2020-2025)
Table 71. Global GLP-1 Therapy Price (US$/Unit) by Application (2026-2031)
Table 72. Novo Nordisk Company Information
Table 73. Novo Nordisk Description and Business Overview
Table 74. Novo Nordisk GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Novo Nordisk GLP-1 Therapy Product
Table 76. Novo Nordisk Recent Developments/Updates
Table 77. Eli Lilly Company Information
Table 78. Eli Lilly Description and Business Overview
Table 79. Eli Lilly GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Eli Lilly GLP-1 Therapy Product
Table 81. Eli Lilly Recent Developments/Updates
Table 82. Sanofi Company Information
Table 83. Sanofi Description and Business Overview
Table 84. Sanofi GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi GLP-1 Therapy Product
Table 86. Sanofi Recent Developments/Updates
Table 87. AstraZeneca (historical) Company Information
Table 88. AstraZeneca (historical) Description and Business Overview
Table 89. AstraZeneca (historical) GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. AstraZeneca (historical) GLP-1 Therapy Product
Table 91. AstraZeneca (historical) Recent Developments/Updates
Table 92. Teva Company Information
Table 93. Teva Description and Business Overview
Table 94. Teva GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Teva GLP-1 Therapy Product
Table 96. Teva Recent Developments/Updates
Table 97. Zealand Pharma Company Information
Table 98. Zealand Pharma Description and Business Overview
Table 99. Zealand Pharma GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Zealand Pharma GLP-1 Therapy Product
Table 101. Zealand Pharma Recent Developments/Updates
Table 102. Pfizer Company Information
Table 103. Pfizer Description and Business Overview
Table 104. Pfizer GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Pfizer GLP-1 Therapy Product
Table 106. Pfizer Recent Developments/Updates
Table 107. Merck (MSD) Company Information
Table 108. Merck (MSD) Description and Business Overview
Table 109. Merck (MSD) GLP-1 Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Merck (MSD) GLP-1 Therapy Product
Table 111. Merck (MSD) Recent Developments/Updates
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. GLP-1 Therapy Distributors List
Table 115. GLP-1 Therapy Customers List
Table 116. GLP-1 Therapy Market Trends
Table 117. GLP-1 Therapy Market Drivers
Table 118. GLP-1 Therapy Market Challenges
Table 119. GLP-1 Therapy Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Authors List of This Report
List of Figures
Figure 1. Product Picture of GLP-1 Therapy
Figure 2. Global GLP-1 Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GLP-1 Therapy Market Share by Type: 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Oral Product Picture
Figure 6. Global GLP-1 Therapy Market Value by Feature, (US$ Million) & (2020-2031)
Figure 7. Global GLP-1 Therapy Market Share by Feature: 2024 VS 2031
Figure 8. Long-acting Drugs Product Picture
Figure 9. Short-acting Drugs Product Picture
Figure 10. Global GLP-1 Therapy Market Value by Channel, (US$ Million) & (2020-2031)
Figure 11. Global GLP-1 Therapy Market Share by Channel: 2024 VS 2031
Figure 12. Online Sales Product Picture
Figure 13. Offline Sales Product Picture
Figure 14. Global GLP-1 Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 15. Global GLP-1 Therapy Market Share by Application: 2024 & 2031
Figure 16. Type 2 Diabetes
Figure 17. Obesity/Weight Management
Figure 18. Other
Figure 19. Global GLP-1 Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global GLP-1 Therapy Market Size (2020-2031) & (US$ Million)
Figure 21. Global GLP-1 Therapy Sales (2020-2031) & (K Units)
Figure 22. Global GLP-1 Therapy Average Price (US$/Unit) & (2020-2031)
Figure 23. GLP-1 Therapy Report Years Considered
Figure 24. GLP-1 Therapy Sales Share by Manufacturers in 2024
Figure 25. Global GLP-1 Therapy Revenue Share by Manufacturers in 2024
Figure 26. Global 5 and 10 Largest GLP-1 Therapy Players: Market Share by Revenue in GLP-1 Therapy in 2024
Figure 27. GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Global GLP-1 Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 29. North America GLP-1 Therapy Sales Market Share by Country (2020-2031)
Figure 30. North America GLP-1 Therapy Revenue Market Share by Country (2020-2031)
Figure 31. United States GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Canada GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Europe GLP-1 Therapy Sales Market Share by Country (2020-2031)
Figure 34. Europe GLP-1 Therapy Revenue Market Share by Country (2020-2031)
Figure 35. Germany GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. France GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. U.K. GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Italy GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Russia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific GLP-1 Therapy Sales Market Share by Region (2020-2031)
Figure 41. Asia Pacific GLP-1 Therapy Revenue Market Share by Region (2020-2031)
Figure 42. China GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Japan GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. South Korea GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. India GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Australia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. China Taiwan GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Southeast Asia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America GLP-1 Therapy Sales Market Share by Country (2020-2031)
Figure 50. Latin America GLP-1 Therapy Revenue Market Share by Country (2020-2031)
Figure 51. Mexico GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Colombia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa GLP-1 Therapy Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa GLP-1 Therapy Revenue Market Share by Country (2020-2031)
Figure 57. Turkey GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE GLP-1 Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of GLP-1 Therapy by Type (2020-2031)
Figure 61. Global Revenue Market Share of GLP-1 Therapy by Type (2020-2031)
Figure 62. Global GLP-1 Therapy Price (US$/Unit) by Type (2020-2031)
Figure 63. Global Sales Market Share of GLP-1 Therapy by Application (2020-2031)
Figure 64. Global Revenue Market Share of GLP-1 Therapy by Application (2020-2031)
Figure 65. Global GLP-1 Therapy Price (US$/Unit) by Application (2020-2031)
Figure 66. GLP-1 Therapy Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232